Logo image of WKME

WALKME LTD (WKME) Stock Fundamental Analysis

USA - NASDAQ:WKME - IL0011765851 - Common Stock

13.95 USD
0 (0%)
Last: 9/11/2024, 8:00:44 PM
13.93 USD
-0.02 (-0.14%)
After Hours: 9/11/2024, 8:00:44 PM
Fundamental Rating

4

Overall WKME gets a fundamental rating of 4 out of 10. We evaluated WKME against 281 industry peers in the Software industry. No worries on liquidiy or solvency for WKME as it has an excellent financial health rating, but there are worries on the profitability. WKME has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year WKME was profitable.
In the past year WKME had a positive cash flow from operations.
WKME had negative earnings in each of the past 5 years.
WKME had negative operating cash flow in 4 of the past 5 years.
WKME Yearly Net Income VS EBIT VS OCF VS FCFWKME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

WKME has a Return On Assets of -9.47%. This is comparable to the rest of the industry: WKME outperforms 42.25% of its industry peers.
Looking at the Return On Equity, with a value of -17.23%, WKME is in line with its industry, outperforming 45.77% of the companies in the same industry.
Industry RankSector Rank
ROA -9.47%
ROE -17.23%
ROIC N/A
ROA(3y)-18.22%
ROA(5y)-23.44%
ROE(3y)-30.9%
ROE(5y)-46.52%
ROIC(3y)N/A
ROIC(5y)N/A
WKME Yearly ROA, ROE, ROICWKME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 85.25%, WKME belongs to the top of the industry, outperforming 92.25% of the companies in the same industry.
In the last couple of years the Gross Margin of WKME has grown nicely.
The Profit Margin and Operating Margin are not available for WKME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5YN/A
WKME Yearly Profit, Operating, Gross MarginsWKME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

WKME does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WKME has been increased compared to 1 year ago.
There is no outstanding debt for WKME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
WKME Yearly Shares OutstandingWKME Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M 80M
WKME Yearly Total Debt VS Total AssetsWKME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.93 indicates that WKME is not a great score, but indicates only limited risk for bankruptcy at the moment.
WKME has a Altman-Z score of 2.93. This is comparable to the rest of the industry: WKME outperforms 53.87% of its industry peers.
There is no outstanding debt for WKME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.93
ROIC/WACCN/A
WACC9.55%
WKME Yearly LT Debt VS Equity VS FCFWKME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

WKME has a Current Ratio of 2.04. This indicates that WKME is financially healthy and has no problem in meeting its short term obligations.
WKME's Current ratio of 2.04 is fine compared to the rest of the industry. WKME outperforms 61.97% of its industry peers.
A Quick Ratio of 2.04 indicates that WKME has no problem at all paying its short term obligations.
WKME's Quick ratio of 2.04 is fine compared to the rest of the industry. WKME outperforms 61.97% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04
WKME Yearly Current Assets VS Current LiabilitesWKME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

6

3. Growth

3.1 Past

WKME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 181.25%, which is quite impressive.
WKME shows a small growth in Revenue. In the last year, the Revenue has grown by 4.89%.
The Revenue has been growing by 21.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)181.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.11%
Revenue 1Y (TTM)4.89%
Revenue growth 3Y21.65%
Revenue growth 5YN/A
Sales Q2Q%5.07%

3.2 Future

The Earnings Per Share is expected to grow by 71.00% on average over the next years. This is a very strong growth
WKME is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.86% yearly.
EPS Next Y643.24%
EPS Next 2Y204.11%
EPS Next 3Y147.19%
EPS Next 5Y71%
Revenue Next Year5.65%
Revenue Next 2Y7.5%
Revenue Next 3Y9.56%
Revenue Next 5Y8.86%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
WKME Yearly Revenue VS EstimatesWKME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
WKME Yearly EPS VS EstimatesWKME Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 -0.6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 53.65 indicates a quite expensive valuation of WKME.
WKME's Price/Earnings ratio is in line with the industry average.
WKME's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.70.
The Price/Forward Earnings ratio is 50.28, which means the current valuation is very expensive for WKME.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WKME is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.15. WKME is valued rather expensively when compared to this.
Industry RankSector Rank
PE 53.65
Fwd PE 50.28
WKME Price Earnings VS Forward Price EarningsWKME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

WKME's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. WKME is cheaper than 77.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.09
EV/EBITDA N/A
WKME Per share dataWKME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

WKME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WKME's earnings are expected to grow with 147.19% in the coming years.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y204.11%
EPS Next 3Y147.19%

More info and screens

0

5. Dividend

5.1 Amount

WKME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WALKME LTD

NASDAQ:WKME (9/11/2024, 8:00:44 PM)

After market: 13.93 -0.02 (-0.14%)

13.95

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-01 2024-08-01/amc
Earnings (Next)N/A N/A
Inst Owners9.06%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.30B
Analysts51.67
Price Target14.08 (0.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)133.64%
Min EPS beat(2)84.28%
Max EPS beat(2)183%
EPS beat(4)4
Avg EPS beat(4)217.58%
Min EPS beat(4)84.28%
Max EPS beat(4)482.59%
EPS beat(8)8
Avg EPS beat(8)132.3%
EPS beat(12)11
Avg EPS beat(12)93.01%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.74%
Min Revenue beat(2)-2.09%
Max Revenue beat(2)-1.38%
Revenue beat(4)0
Avg Revenue beat(4)-1.76%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)-1.38%
Revenue beat(8)0
Avg Revenue beat(8)-1.38%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-8.05%
EPS NQ rev (3m)-10.24%
EPS NY rev (1m)0.16%
EPS NY rev (3m)7.1%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 53.65
Fwd PE 50.28
P/S 4.76
P/FCF 28.09
P/OCF 27.79
P/B 4.95
P/tB 4.98
EV/EBITDA N/A
EPS(TTM)0.26
EY1.86%
EPS(NY)0.28
Fwd EY1.99%
FCF(TTM)0.5
FCFY3.56%
OCF(TTM)0.5
OCFY3.6%
SpS2.93
BVpS2.82
TBVpS2.8
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.47%
ROE -17.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.25%
FCFM 16.93%
ROA(3y)-18.22%
ROA(5y)-23.44%
ROE(3y)-30.9%
ROE(5y)-46.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5YN/A
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 8.18%
Cap/Sales 0.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z 2.93
F-Score6
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)42.88%
Cap/Depr(5y)43.23%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)181.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.11%
EPS Next Y643.24%
EPS Next 2Y204.11%
EPS Next 3Y147.19%
EPS Next 5Y71%
Revenue 1Y (TTM)4.89%
Revenue growth 3Y21.65%
Revenue growth 5YN/A
Sales Q2Q%5.07%
Revenue Next Year5.65%
Revenue Next 2Y7.5%
Revenue Next 3Y9.56%
Revenue Next 5Y8.86%
EBIT growth 1Y61.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year328.4%
EBIT Next 3Y100.46%
EBIT Next 5Y56.37%
FCF growth 1Y178.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y187.4%
OCF growth 3YN/A
OCF growth 5YN/A